1. Experian Health and NCPDP Align to Improve Patient Identification Across the Healthcare Ecosystem

    Experian Health and NCPDP today announced their strategic alliance to provide a vendor neutral solution to address the complexities of managing patient identification. With a shared vision to create solutions and leverage data for the common good, this alliance brings an innovative matching solution that provides the framework for establishing a unique patient identifier to address patient safety, financial and operational challenges across the U.S. healthcare ecosystem.

    Read More

  2. Pharmacist eCare Plan Version 1.0

    WG10 Professional Pharmacy Services has developed the Pharmacist eCare Plan Version 1.0: Guidance on the Use of the HL7 CDA Consolidated Templates for Clinical Notes R2.1 Care Plan (on the website at the tab titled Recommendations for Pharmacists on the Use of HL7 Consolidated CDA Templates) to enable pharmacists to capture their assessments of patient health status and health concerns, mutually defined patient care goals, recommendations, interventions and outcomes and to share them with other care providers, payers and the patient.

    Read More

  3. Real-time Prescription Benefit Inquiry Task Group Webinars

    The NCPDP MC Real-time Prescription Benefit Inquiry Task Group is holding two complimentary informational webinars about a potential new standard. 

    Read More

  4. Call for Proposals Deadline Extended!

    The deadline for industry thought leaders and innovators to submit proposals for the 2017 Annual Technology & Business Conference has been extended to Thursday, September 8, 2016 at 5:00 P.M. EDT. Don't miss out on this opportunity to join us in celebrating our 40th Anniversary and to gain visibility in front of an anticipated record number of attendees!

    Read More

  5. Enforcement Policy on NHRIC and NDC Numbers

    The Federal Drug Administration (FDA) has released final guidance concerning the continued use of National Health Related Item Code (NHRIC) and National Drug Code (NDC). Although NCPDP and other stakeholders requested a 10-year transition period, the guidance offers enforcement discretion for finished devices manufactured and labeled prior to September 24, 2021, or five years.  Significantly, the FDA removed the three-year inventory depletion language.

    Read More

For problems with the site please contact us at webmaster@ncpdp.org